Factors affecting the seroconversion rate of 12-month-old babies after the first injection of measles vaccine in the southeast of Iran
- 26 July 2016
- journal article
- research article
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 12 (12) , 3118-3124
Abstract
Within the past few years, several measles outbreaks have occurred in the southeast of Iran. To learn about the effectiveness of the immunization services for producing a serologic response against measles, this follow-up study was designed and implemented in the southeast of Iran. In Iran, all routine immunization services provided by the public sector are free of charge. The follow-up study was designed and implemented in 5 Urban Health Centers located in 3 districts of Sistan-va-BaluchestanProvince, Iran. In the pre-vaccination phase, 270 12-month-old babies were blood sampled; and in the post-vaccination phase, 4 to 7 weeks after Measles, Mumps, Rubella (MMR) vaccination, 236 of them were blood sampled (34 dropouts), and their sera were tested for IgG anti-measles antibodies, using indirect ELISA, in the National Reference Measles Laboratory. Out of the 236 participants, who had been blood sampled in the post-vaccination phase, 10 (3.7%) were excluded from the calculations of seroconversion rate, because they had protective levels of antibody before the vaccination. The seroconversion rate for the remaining 226 participants was 91.2% (95% confidence interval: 86.7 to 94.5). Among the variables studied, stunting (height-for-age z-score < −2) showed a strong relationship with the remaining seronegative after the vaccination (odds ratio = 5.6; 95% confidence interval: 1.7–18.2). The chance of seroconversion was inversely related to the mothers' levels of education (up to 9 y of education vs. above nine years) (odds ratio = 0.2; 95% confidence interval: 0.06–0.4). In the study population, the seroconversion rates for anti-measles antibodies after MMR vaccination are acceptable, even though in order to achieve the elimination goal, higher standards need to be achieved.Keywords
This publication has 26 references indexed in Scilit:
- Factors affecting the infant antibody response to measles immunisation in Entebbe-UgandaBMC Public Health, 2013
- Successful Control and Impending Elimination of Measles in the Islamic Republic of IranThe Journal of Infectious Diseases, 2011
- Estimation of measles vaccine efficacy and critical vaccination coverage in a highly vaccinated populationJournal of The Royal Society Interface, 2010
- The impact of maternal measles–rubella immunization on the 12-month-old infant’s immune response to measles–mumps–rubella vaccine immunogenicityEuropean Journal of Clinical Microbiology & Infectious Diseases, 2009
- Progress in Measles and Rubella Elimination in IranThe Pediatric Infectious Disease Journal, 2007
- The Duration of Maternal Measles Antibodies in ChildrenJournal of Tropical Pediatrics, 2003
- Seroconversion after measles vaccination at nine and fifteen months of ageThe Pediatric Infectious Disease Journal, 2003
- Immunogenicity and Safety of Standard-Titer AIK-C Measles Vaccine in Nine-Month-Old InfantsViral Immunology, 1999
- Seroconversion Rates and Measles Antibody Titers Induced by Measles Vaccination in Latin American Children Six to 12 Months of AgeClinical Infectious Diseases, 1983
- Persistence of maternal antibody in infants beyond 12 months: Mechanism of measles vaccine failureThe Journal of Pediatrics, 1977